Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.28 | 0.07 |
mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.07 |
mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.064 | 0.07 |
mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.07 |
mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.064 | 0.08 |
mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.08 |
mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.08 |
mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.08 |
mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.08 |
mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.08 |